Anti-Phospholipase C gamma 1 (phospho Y771) antibody (ab52207)

Overview

  • Product nameAnti-Phospholipase C gamma 1 (phospho Y771) antibody
    See all Phospholipase C gamma 1 primary antibodies
  • Description
    Rabbit polyclonal to Phospholipase C gamma 1 (phospho Y771)
  • Specificityab52207 detects endogenous levels of PLCG1 only when phosphorylated at tyrosine 771.
  • Tested applicationsIHC-P, WB, ELISAmore details
  • Species reactivity
    Reacts with: Human
    Predicted to work with: Mouse, Rat
  • Immunogen

    Synthesized phosphopeptide derived from human PLCG1 around the phosphorylation site of tyrosine 771 (P-D-YP-G-A).

  • Positive control
    • Human breast carcinoma tissue; extracts from COS7 cells

Properties

Applications

Our Abpromise guarantee covers the use of ab52207 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
IHC-P Use at an assay dependent dilution.
WB 1/500 - 1/1000. Detects a band of approximately 175 kDa (predicted molecular weight: 149 kDa).
ELISA 1/40000.

Target

  • FunctionPlays a role in actin reorganization and cell migration. The production of the second messenger molecules diacylglycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) is mediated by activated phosphatidylinositol-specific phospholipase C enzymes. Major substrate for heparin-binding growth factor 1 (acidic fibroblast growth factor)-activated tyrosine kinase.
  • Sequence similaritiesContains 1 C2 domain.
    Contains 1 EF-hand domain.
    Contains 2 PH domains.
    Contains 1 PI-PLC X-box domain.
    Contains 1 PI-PLC Y-box domain.
    Contains 2 SH2 domains.
    Contains 1 SH3 domain.
  • DomainThe SH3 domain mediates interaction with CLNK (By similarity). The SH3 domain also mediates interaction with RALGPS1.
  • Post-translational
    modifications
    The receptor-mediated activation of PLC-gamma-1 and PLC-gamma-2 involves their phosphorylation by tyrosine kinases in response to ligation of a variety of growth factor receptors and immune system receptors. May be dephosphorylated by PTPRJ.
    Ubiquitinated by CBLB in activated T-cells.
  • Cellular localizationCell projection > lamellipodium. Cell projection > ruffle. Rapidly redistributed to ruffles and lamellipodia structures in response to epidermal growth factor (EGF) treatment.
  • Information by UniProt
  • Database links
  • Alternative names
    • 1 phosphatidyl D myo inositol 4 5 bisphosphate antibody
    • 1 phosphatidylinositol 4 5 bisphosphate antibody
    • 1 phosphatidylinositol 4 5 bisphosphate phosphodiesterase gamma 1 antibody
    • 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase gamma-1 antibody
    • Inositoltrisphosphohydrolase antibody
    • Monophosphatidylinositol phosphodiesterase antibody
    • NCKAP3 antibody
    • Phosphatidylinositol phospholipase C antibody
    • Phosphodiesterase gamma 1 antibody
    • Phosphoinositidase C antibody
    • Phosphoinositide phospholipase C antibody
    • Phosphoinositide phospholipase C-gamma-1 antibody
    • Phospholipase C 148 antibody
    • Phospholipase C gamma 1 antibody
    • Phospholipase C-gamma-1 antibody
    • Phospholipase C-II antibody
    • PLC 1 antibody
    • PLC 148 antibody
    • PLC gamma 1 antibody
    • PLC II antibody
    • PLC-148 antibody
    • PLC-gamma-1 antibody
    • PLC-II antibody
    • PLC1 antibody
    • PLC148 antibody
    • PLCG1 antibody
    • PLCG1_HUMAN antibody
    • PLCgamma1 antibody
    • PLCII antibody
    • Triphosphoinositide phosphodiesterase antibody
    see all

Anti-Phospholipase C gamma 1 (phospho Y771) antibody images

  • This image shows human breast carcinoma tissue stained with ab52207 at a dilution of 1/50 - 1/100. Right hand image: tissue treated with immunising peptide; left hand image: untreated.
  • All lanes : Anti-Phospholipase C gamma 1 (phospho Y771) antibody (ab52207) at 1/500 dilution

    Lane 1 : Extracts from COS7 cells treated with EGF (200ng/ml, 30min) with no immunising peptide
    Lane 2 : Extracts from COS7 cells treated with EGF (200ng/ml, 30min) with immunising peptide


    Predicted band size : 149 kDa
    Observed band size : ~175 kDa (why is the actual band size different from the predicted?)

References for Anti-Phospholipase C gamma 1 (phospho Y771) antibody (ab52207)

ab52207 has not yet been referenced specifically in any publications.

Product Wall

There are currently no Abreviews or Questions for ab52207.
Please use the links above to contact us or submit feedback about this product.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"